source
- TRexBio and Retension raise $161.7M in IPOs as biotech fundraising surge continuesTRexBio and Retension Pharmaceuticals are slated to begin trading on Friday, together raising $161.7 million. Their offerings push the number of biotech IPOs this year to 29, underscoring a continu…
- AI startup Chai Discovery inks GSK deal to develop biologics using artificial intelligenceChai Discovery, an artificial‑intelligence focused biotech, has signed a collaboration agreement with GlaxoSmithKline to create biologic medicines using its AI platform. The partnership will lever…